These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21407946)
41. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886 [TBL] [Abstract][Full Text] [Related]
42. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Perry W; Minassian A; Paulus MP; Young JW; Kincaid MJ; Ferguson EJ; Henry BL; Zhuang X; Masten VL; Sharp RF; Geyer MA Arch Gen Psychiatry; 2009 Oct; 66(10):1072-80. PubMed ID: 19805697 [TBL] [Abstract][Full Text] [Related]
43. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial. Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549 [TBL] [Abstract][Full Text] [Related]
44. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M; J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508 [TBL] [Abstract][Full Text] [Related]
45. The trajectory of cognitive functioning following first episode mania: A 12-month follow-up study. Daglas R; Allott K; Yücel M; Pantelis C; Macneil CA; Berk M; Cotton SM Aust N Z J Psychiatry; 2016 Dec; 50(12):1186-1197. PubMed ID: 26698823 [TBL] [Abstract][Full Text] [Related]
46. Content-specificity of dysfunctional cognitions for patients with bipolar mania versus unipolar depression: a preliminary study. Goldberg JF; Wenze SJ; Welker TM; Steer RA; Beck AT Bipolar Disord; 2005 Feb; 7(1):49-56. PubMed ID: 15654932 [TBL] [Abstract][Full Text] [Related]
47. Predominant mania course in Indian patients with bipolar I disorder. Rangappa SB; Munivenkatappa S; Narayanaswamy JC; Jain S; Reddy YC Asian J Psychiatr; 2016 Aug; 22():22-7. PubMed ID: 27520890 [TBL] [Abstract][Full Text] [Related]
48. Mania symptoms in a Swedish longitudinal population study: The roles of childhood trauma and neurodevelopmental disorders. Gajwani R; Dinkler L; Lundström S; Lichtenstein P; Gillberg C; Minnis H J Affect Disord; 2021 Feb; 280(Pt A):450-456. PubMed ID: 33242716 [TBL] [Abstract][Full Text] [Related]
49. Indicators of mania in depressed outpatients: a retrospective analysis of data from the Kansas 1500 study. Othmer E; Desouza CM; Penick EC; Nickel EJ; Hunter EE; Othmer SC; Powell BJ; Hall SB J Clin Psychiatry; 2007 Jan; 68(1):47-51. PubMed ID: 17284129 [TBL] [Abstract][Full Text] [Related]
50. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). Akiskal HS; Hantouche EG; Bourgeois ML; Azorin JM; Sechter D; Allilaire JF; Lancrenon S; Fraud JP; Châtenet-Duchêne L J Affect Disord; 1998 Sep; 50(2-3):175-86. PubMed ID: 9858077 [TBL] [Abstract][Full Text] [Related]
51. Gray matter voxel-based morphometry in mania and remission states of children with bipolar disorder. Xiao Q; Zhong Y; Jiao Q; Lu G; Su Y J Affect Disord; 2020 May; 268():47-54. PubMed ID: 32158006 [TBL] [Abstract][Full Text] [Related]
52. Qualitative differences in manic symptoms during mixed versus pure mania. Goldberg JF; Garno JL; Portera L; Leon AC; Kocsis JH Compr Psychiatry; 2000; 41(4):237-41. PubMed ID: 10929789 [TBL] [Abstract][Full Text] [Related]
54. Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute mania. Shi L; Schuh LM; Trzepacz PT; Huang LX; Namjoshi MA; Tohen M Curr Med Res Opin; 2004 Sep; 20(9):1371-6. PubMed ID: 15383185 [TBL] [Abstract][Full Text] [Related]
55. Primary mania versus HIV-related secondary mania in Uganda. Nakimuli-Mpungu E; Musisi S; Mpungu SK; Katabira E Am J Psychiatry; 2006 Aug; 163(8):1349-54; quiz 1480. PubMed ID: 16877646 [TBL] [Abstract][Full Text] [Related]
56. Structural brain changes in first episode mania with and without psychosis: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Keramatian K; Dhanoa T; McGirr A; Lang DJ; Honer WG; Lam RW; Yatham LN World J Biol Psychiatry; 2018; 19(sup2):S30-S40. PubMed ID: 27762161 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial. Moghaddam HS; Bahmani S; Bayanati S; Mahdavinasa M; Rezaei F; Akhondzadeh S Int Clin Psychopharmacol; 2020 Mar; 35(2):81-88. PubMed ID: 31743233 [TBL] [Abstract][Full Text] [Related]
58. A pilot study of topiramate as monotherapy in the treatment of acute mania. Calabrese JR; Keck PE; McElroy SL; Shelton MD J Clin Psychopharmacol; 2001 Jun; 21(3):340-2. PubMed ID: 11386499 [TBL] [Abstract][Full Text] [Related]